Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectafer in iron deficient patients with fibromyalgia
NCT02409459Phase 2Completed
- Sponsor
- American Regent, Inc.
- Start
- Mar 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ferric carboxymaltose in fibromyalgia (FM), iron deficiency anemia (IDA), sponsored by American Regent, Inc.. Started Mar 2015; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
fibromyalgia (FM)iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT02409459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02409459.